Guide for Authors
An official journal of the
Society for Developmental Biology
!!! Important information for NIH authors !!!
Developmental Biology publishes original research on mechanisms
of development, differentiation, and growth in animals and plants at the molecular, cellular, and genetic levels. Areas of particular
emphasis include transcriptional control mechanisms, embryonic patterning, cell-cell interactions, growth factors and signal transduction,
and regulatory hierarchies.
Scientific Guidelines for Authors submitting to Developmental Biology
Developmental
Biology's goal is to publish high quality papers providing causal insight into the cellular and molecular mechanisms that govern
developmental processes.
Studies which simply confirm an established functional role for a developmental component by presenting
analysis in a new species lack sufficient novelty for consideration.
Similarly, purely descriptive spatial gene expression or gene
phylogeny articles are not considered for publication unless they are notably of consequence and are of particular value to the field.
Types of paper
Developmental Biology publishes Original Research Papers, Review Articles, Essays,
Perspectives, and articles for the Genomes and Developmental Control and Evolution of Developmental Control Mechanisms sections.
Original Research Papers
Developmental Biology seeks to publish only the very best papers that contribute new information
to our understanding of developmental mechanisms. Questions are frequently raised about "descriptive" papers. Such papers are
appropriate for DB if they provide important new insights. This would not include, for example, a description of the expression pattern
of a gene in one species that has already been described in another species, or an expression pattern with no obvious link to a developmental
process.
We require that manuscripts specifically address biological relevance. While morpholino, microarray and RNAi studies may
be acceptable, they must contain adequate controls to be considered for publication.
The following types of Original Research
papers have specific guidelines:
Expression profiling and gene expression studies must contain supporting functional
data. Studies solely based on analysis of expression by microarray, northern blots, PCR or
in situ hybridization are too descriptive
or preliminary to justify full review.
Gene knock-down experiments:
Experiments using interfering DNA or proteins to address
gene function are expected to be highly controlled. In particular, experiments with
Morpholino,
RNAi, siRNA or dominant negative constructs are expected to contain very precise controls to address the specificity of the effects observed.
Studies in which the expression, structure or function of a gene/protein is altered but lead to no
phenotypic consequences
are not appropriate. Furthermore, studies of mutants which simply show that a gene/protein is required for development will be discouraged
unless attempts are made to address the mechanistic basis, causal roles or tissues and processes affected.
Experiments using
stem
cells must advance our understanding of biological functioning. Studies that simply grow/isolate stem cells from a tissue and show
what markers they express are not appropriate.
Studies using
cell culture must show direct (in vivo) relevance in a developmental
context.
Papers usually do not exceed 15,000 words.
Review Articles
Review articles are intended to reach a broad audience of readers from investigators in the field to new graduate students learning
the material for the first time. Review articles are subject to the same review process as original papers, but may receive expedited
consideration. Manuscripts should be prepared according to the general guidelines given below. The Materials and Methods, Results, and
Discussion sections may be replaced with appropriate alternatives; an abstract is still required. The editor-in-chief and the reviews
editor invite inquiries and suggestions for timely and provocative review articles.
Perspectives
Perspectives are short
scholarly articles that express an opinion on a body of work, an idea or concept. They may relate to historical material or may honor
a specific scientist or technique. They are not, however, letters to the editor or a forum for discussing a specific article or author
published in the journal. Word limit: 2,000
Essays
Essays are longer scholarly articles that express an opinion on
a body of work, an idea or concept. They may in part review articles covering a narrow topic or controversial field and put forward a
hypothesis. Unlike reviews they do not necessarily have to address a topic in its entirety but may concentrate on one specific aspect
of research. The work should contain references and figures and generally not contain more than 8,000 words.
Genomes and Developmental Control
The Genomes and Developmental Control section is dedicated to
papers that address analysis of developmental cis-regulatory systems; developmental genomics; transcriptional mechanisms in development,
analysis of specific developmental processes, and system-level approaches to such networks; comparative analysis and evolution of regulatory
systems; and computational advances that illuminate the identification and the structure/function relationships of developmental control
systems. Papers selected for this section will appear together on a monthly basis. As always, we are dedicated to rapidly reviewing papers.
Evolution of Developmental Control Mechanisms
The goal of the Evolution of Developmental Control Mechanisms section is
to provide a focus on research that examines evolutionary questions from a developmental perspective. The section is not intended for
accounts of descriptive observations or for reports of gene expression, but rather for research that illuminates mechanistic differences
in processes and causes of evolutionary change in developmental programs. The intersection of embryology and evolution has formed a framework
for understanding evolutionary processes since the time of Darwin. The recent availability of genomic sequence information has greatly
facilitated identification of homologous genes and their regulatory regions across diverse species, from unicellular organisms to plants,
vertebrates, and invertebrates. The advent of powerful tools for performing experimental analyses (RNAi, antisense morpholino oligonucleotides,
transgenesis, pharmacological intervention, etc.) now allows testing and comparison of gene deployment and function across diverse species.
This section aims to provide a venue of choice for such in-depth comparative functional analyses.
Contact details for submission
Articles for Developmental Biology should be submitted via the journal's online submission
system,
http://ees.elsevier.com/developmentalbiology.
Customer support is available 24/7:
Please use our help site
at:
http://epsupport.elsevier.com/. Here you will be able to learn more about the online submission system via interactive
tutorials, explore a range of problem solutions via our knowledgebase, and find answers to frequently asked questions. You will also
find our 24/7 support contact details should you need any assistance from one of our customer service representatives.
For questions
on the reviewing and submission process, please contact:
Developmental Biology Editorial Office
525 B Street, Suite
1800
San Diego, CA 92101-4495, USA
Tel: (619) 699-6351
Fax: (619) 699-6211
E-mail:
db@elsevier.com
Ethics in Publishing
For information
on Ethics in Publishing and Ethical guidelines for journal publication see
http://www.elsevier.com/publishingethics and
http://www.elsevier.com/ethicalguidelines.
Conflict of interest
All
authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships
with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived
to influence, their work. See also
http://www.elsevier.com/conflictsofinterest.
Submission declaration
Submission of an article implies that the work described has not been published previously (except
in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication
elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was
carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without
the written consent of the copyright-holder.
Copyright
Upon acceptance
of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright see
http://www.elsevier.com/copyright).
Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding
author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this
agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation
within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other
derivative works, including compilations and translations (please consult
http://www.elsevier.com/permissions). If excerpts
from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s)
in the article. Elsevier has preprinted forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details
you are referred to:
http://www.elsevier.com/authorsrights.
Role of the
funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation
of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation
of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source(s) had no such
involvement then this should be stated. Please see
http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose
articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions
of their grant awards. To learn more about existing agreements and policies please visit
http://www.elsevier.com/fundingbodies.
Language and language services
Please write your text in good English (American or British usage is accepted,
but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission
please visit
http://www.elsevier.com/languagepolishing or our customer support site at
http://epsupport.elsevier.com
for more information. Please note Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside
vendors through our services or in any advertising. For more information please refer to our Terms & Conditions:
http://www.elsevier.com/termsandconditions.
Submission
Submission to this journal proceeds totally online and you will be guided stepwise through
the creation and uploading of your files. The system automatically converts source files to a single PDF file of the article, which is
used in the peer-review process. Please note that even though manuscript source files are converted to PDF files at submission for the
review process, these source files are needed for further processing after acceptance. All correspondence, including notification of
the Editor's decision and requests for revision, takes place by e-mail removing the need for a paper trail.
Referees
Please submit, with the manuscript, the names, addresses and e-mail addresses of 3 potential referees.
Note that the editor retains the sole right to decide whether or not the suggested reviewers are used.
Additional information
Cover Submissions
Color figures for exclusive use as cover illustrations
may be submitted by authors who are also submitting a manuscript for consideration. Such illustrations do not need to relate to the manuscript
being submitted but should relate to the larger scope and focus of
Developmental Biology. A legend of 100 or fewer words should
accompany each image.
Materials
Publication of a research article in
Developmental Biology is taken to imply
that the authors are prepared to distribute all non-commercially obtained materials used in the experiments (e.g. cells, DNA, antibodies,
primary data), to other academic researchers for their own use or for verification. All nucleic acid and protein sequences must have
been deposited in the appropriate databases and the Accession Numbers cited in the paper.
Data from microarray and other similar
screens:
Please see the MGED open letter specifying microarray standards at
http://www.mged.org/Workgroups/MIAME/miame_checklist.html.
Authors submitting manuscripts relying on microarray or similar screens must supply the data as Supplementary data (see below) at the
time of submission, along with the completed MIAME checklist. The data must be MIAME-compliant and supplied in a form that is widely
accessible. The microarray data must also be submitted to either the GEO (
http://www.ncbi.nlm.nih.gov/geo/) or ArrayExpress
(
http://www.ebi.ac.uk/arrayexpress/) databases, with accession numbers at or before acceptance of the paper for publication.
The editors understand that on occasion authors may not feel it appropriate to deposit the entire data set at the time of publication
of this paper. We are therefore willing to consider exceptions to this requirement in response to a request from the authors, which must
be made at the time of initial submission or as part of an informal pre-submission enquiry.
Mouse Gene Expression Data
Upon acceptance of the manuscript for publication in DB, authors reporting mouse gene expression data from RNA in situ hybridization,
immunohistochemistry, Northern blot, Western blot and RT-PCR experiments are requested to submit pertinent data to the Mouse Gene Expression
Database (GXD). These data submissions will receive accession numbers that may then be inserted into the manuscript. Please see GXD's
guidelines for electronic data submission at
http://www.informatics.jax.org/mgihome//GXD/GEN/gxd_submission_guidelines.shtml.
US National Institutes of Health (NIH) posting ("Public Access") policy
As a service
to our authors, Elsevier will deposit to PubMed Central (PMC) author manuscripts on behalf of Elsevier authors reporting NIH funded research.
This service is a continuation of Elsevier's 2005 agreement with the NIH when the NIH introduced their voluntary 'Public Access
Policy'. See
http://www.elsevier.com/wps/find/authors.authors/nihauthorrequest.
Access to non-subscribers 12
months after publication
Elsevier is pleased to announce that all articles published in
Developmental Biology are accessible
to non-subscribers 12 months after publication via ScienceDirect (
http://www.sciencedirect.com/science/journal/00121606).
Policy for Wellcome Trust funded authors
http://www.elsevier.com/wps/find/authorshome.authors/wellcometrustauthors.
Use of wordprocessing software
It
is important that the file be saved in the native format of the wordprocessor used. The text should be in single-column format. Keep
the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular,
do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts
etc. Do not embed "graphically designed" equations or tables, but prepare these using the wordprocessor's facility. When preparing tables,
if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs,
not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also
the Guide to Publishing with Elsevier:
http://www.elsevier.com/guidepublication). Do not import the figures into the text
file but, instead, indicate their approximate locations directly in the electronic text and on the manuscript. See also the section on
Electronic illustrations.
To avoid unnecessary errors you are strongly advised to use the "spell-check" and "grammar-check" functions
of your wordprocessor.
Article structure
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature
survey or a summary of the results.
Material and methods
Provide
sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications
should be described.
Results
Results should be clear and concise.
Discussion
This should explore the significance of the results of the work, not repeat them. A combined
Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which
may stand alone or form a subsection of a Discussion or Results and Discussion section.
Essential title page information
•
Title.
Concise and informative. Titles are often used in information-retrieval
systems. Avoid abbreviations and formulae where possible.
•
Author names and affiliations.
Where the family name
may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work
was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in
front of the appropriate address. Provide the full postal address of each affiliation, including the country name, and, if available,
the e-mail address of each author.
•
Corresponding author.
Clearly indicate who will handle correspondence at
all stages of refereeing and publication, also post-publication.
Ensure that telephone and fax numbers (with country and area code)
are provided in addition to the e-mail address and the complete postal address.
•
Present/permanent address.
If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address" (or "Permanent
address") may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained
as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
A concise and factual abstract is required. The abstract should state briefly the purpose of the research, the
principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone.
For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon
abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.
Keywords
Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding
general and plural terms and multiple concepts (avoid, for example, "and", "of"). Be sparing with abbreviations: only abbreviations firmly
established in the field may be eligible. These keywords will be used for indexing purposes.
Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help
during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).
Accession numbers
Accession numbers are unique identifiers in bioinformatics allocated to nucleotide and
protein sequences to allow tracking of different versions of that sequence record and the associated sequence in a data repository [e.g.,
databases at the National Center for Biotechnical Information (NCBI) at the National Library of Medicine ('GenBank') and the Worldwide
Protein Data Bank]. There are different types of accession numbers in use based on the type of sequence cited, each of which uses a different
coding. Authors should explicitly mention the
type of accession number together with the actual number, bearing in mind that
an error in a letter or number can result in a dead link in the online version of the article. Please use the following format: accession
number type ID: xxxx (e.g., MMDB ID: 12345; PDB ID: 1TUP). Note that in the final version of the
electronic copy, accession
numbers will be linked to the appropriate database, enabling readers to go directly to that source from the article.
Artwork
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics"
or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number
the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
•
Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
• Submit
each figure as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless
of the application used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats
(note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings.
Embed the font or save the text as "graphics".
TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a
minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications
please supply "as is".
Please do not:
• Supply embedded graphics in your wordprocessor (spreadsheet, presentation)
document;
• Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
•
Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Color artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office
files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure,
at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) in addition to color
reproduction in print. For further information on the preparation of electronic artwork, please see
http://www.elsevier.com/artworkinstructions.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached
to the figure. A caption should comprise a brief title (
not on the figure itself) and a description of the illustration. Keep
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the
table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that
the data presented in tables do not duplicate results described elsewhere in the article.
References
Citation in text
Please ensure that every reference
cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full.
Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these
references are included in the reference list they should follow the standard reference style of the journal and should include a substitution
of the publication date with either "Unpublished results" or "Personal communication" Citation of a reference as "in press" implies that
the item has been accepted for publication.
Web references
As a minimum,
the full URL should be given. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.),
should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired,
or can be included in the reference list.
References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations in the text) to other articles
in the same Special Issue.
Reference style
Text: All citations
in the text should refer to:
1.
Single author: the author's name (without initials, unless there is ambiguity) and the year
of publication;
2.
Two authors: both authors' names and the year of publication;
3.
Three or more authors:
first author's name followed by "et al." and the year of publication.
Citations may be made directly (or parenthetically). Groups
of references should be listed first alphabetically, then chronologically.
Examples: "as demonstrated (Allan, 1996a, 1996b, 1999;
Allan and Jones, 1995). Kramer et al. (2000) have recently shown ...."
List: References should be arranged first alphabetically
and then further sorted chronologically if necessary. More than one reference from the same author(s) in the same year must be identified
by the letters "a", "b", "c", etc., placed after the year of publication.
Examples:
Reference to a journal publication:
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2000. The art of writing a scientific article. J. Sci. Commun. 163, 51-59.
Reference
to a book:
Strunk Jr., W., White, E.B., 1979. The Elements of Style, third ed. Macmillan, New York.
Reference to a chapter in
an edited book:
Mettam, G.R., Adams, L.B., 1999. How to prepare an electronic version of your article, in: Jones, B.S., Smith , R.Z.
(Eds.), Introduction to the Electronic Age. E-Publishing Inc., New York, pp. 281-304.
Developmental Biology's reference style is also available from EndNote.
Journal
abbreviations source
Journal names should be abbreviated according to
Index Medicus journal abbreviations:
http://www.nlm.nih.gov/tsd/serials/lji.html;
List of serial title word abbreviations:
http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service):
http://www.cas.org/sent.html.
Supplementary material
Elsevier
accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional
possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips
and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products,
including ScienceDirect:
http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable,
please ensure that data are provided in one of our recommended file formats. Authors should submit the material in electronic format
together with the article and supply a concise and descriptive caption for each file. Video files: please supply 'stills' with your files:
you can choose any frame from the video or make a separate image. These will be used instead of standard icons and will personalize the
link to your supplementary information. For more detailed instructions please visit our artwork instruction pages at
http://www.elsevier.com/artworkinstructions.
Submission checklist
It is hoped that this list will be useful during the final checking of an article
prior to sending it to the journal's Editor for review. Please consult this Guide for Authors for further details of any item.
Ensure
that the following items are present:
One Author designated as corresponding Author:
• E-mail address
• Full
postal address
• Telephone and fax numbers
All necessary files have been uploaded
• Keywords
• All figure
captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been "spellchecked"
and "grammar-checked"
• References are in the correct format for this journal
• All references mentioned in the Reference
list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources
(including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge)
and in print or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the
Web is required, black and white versions of the figures are also supplied for printing purposes
For any further information please
visit our customer support site at
http://epsupport.elsevier.com.
Use of the Digital Object Identifier
The Digital Object Identifier (DOI)
may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to
a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium
for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. The
correct format for citing a DOI is shown as follows (example taken from a document in the journal
Physics Letters B):
doi:10.1016/j.physletb.2003.10.071
When you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download
the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe
Reader version 7 (or higher) available free from
http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how
to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site:
http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and
return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then
mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan
the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the
text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission
from the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure
that all of your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent
corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of
your article if no response is received.
Offprints
The corresponding author,
at no cost, will be provided with a PDF file of the article via e-mail. The PDF file is a watermarked version of the published article
and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use. Additional paper
offprints can be ordered by the authors. An order form with prices will be sent to the corresponding author.
Distribution of Material
Authors who publish a research article in
Developmental Biology must be
prepared to freely distribute to academic researchers for their own use any cell lines, DNA clones, monoclonal antibodies, or genetically
engineered mice described in the article. All genetic-sequence information published in
Developmental Biology must also be deposited
with GenBank or the EMBL Database Library.
For inquiries
relating to the submission of articles (including electronic submission where available) please visit this journal's homepage. You can
track accepted articles at
http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an article's
status has changed. Also accessible from here is information on copyright, frequently asked questions and more. Contact details for questions
arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company